Tag: WHO
-
Nigeria Refines Polio Eradication Strategy with WHO Support toward 2026 Targets
Overview: Nigeria’s renewed push against poliovirus Nigeria is intensifying its fight against poliovirus, aiming to interrupt circulating variant type 2 poliovirus (cVPV2) by 2026. The recent annual strategic retreat of the World Health Organization (WHO) Polio Eradication Programme (PEP) highlighted a concerted plan to strengthen coordination, accelerate vaccination campaigns, and bolster surveillance systems across the…
-
WHO Sounds Alarm Over Drug-Resistant Gonorrhoea Surge and Urges Urgent Action
WHO Raises Alarm Over a Fast-Rising Threat The World Health Organization (WHO) has issued a stark warning about a rapid surge in drug-resistant gonorrhoea, a sexually transmitted infection that is becoming increasingly difficult to treat. In a global trend observed across multiple regions, resistance to antibiotics used to treat gonorrhoea is rising, with ciprofloxacin resistance…
-
WHO Warns of Drug-Resistant Gonorrhoea Surge: Urgent Action Needed as Ciprofloxacin Resistance Hits 95% Globally
Overview: A Growing Threat The World Health Organization (WHO) has issued a stark warning about a rapid surge in drug-resistant gonorrhoea, a sexually transmitted infection that has long challenged medical science. Recent data show ciprofloxacin resistance reaching about 95% globally, a figure that significantly limits one of the historically available antibiotic options. This development signals…
-
WHO Alarm as Drug-Resistant Gonorrhoea Surges: Urgent Action Needed
WHO Warns: A Rapid Rise in Drug-Resistant Gonorrhoea The World Health Organisation (WHO) has issued a stark warning about a sharp increase in drug-resistant gonorrhoea, a sexually transmitted infection that is becoming harder to treat as antibiotic resistance tightens its grip. With resistance to ciprofloxacin now estimated at about 95% globally, researchers and public health…
-
Indonesia Declares End to Poliovirus Type 2 Outbreak After Mass Vaccination Drive
Indonesia Declares End to Poliovirus Type 2 Outbreak Jakarta, 21 November 2025 – Indonesia has officially announced the end of its outbreak of poliovirus type 2, marking a major public health milestone after years of fluctuating immunization coverage. The declaration comes on the back of an intensive vaccination campaign that reached virtually every corner of…
-
Marburg Outbreak in Ethiopia: Nine Infected as WHO Warns of Severe Disease
Overview: A New Marburg Outbreak in Ethiopia Health authorities in Ethiopia confirmed a deadly Marburg virus outbreak in the southern region, marking the country’s first known occurrence of this highly contagious disease. The World Health Organization (WHO) has verified nine laboratory-confirmed cases, with caution that the number may rise as surveillance expands. Marburg is a…
-
Marburg Virus Outbreak in Ethiopia: 9 Cases Confirmed
What is the Marburg virus? The Marburg virus is a highly infectious pathogen in the same family as Ebola. It can cause severe hemorrhagic fever with a high fatality rate, spreading through contact with infected bodily fluids, contaminated surfaces, or sick animals. Public health officials emphasize that while Marburg is rare, outbreaks demand swift and…
-
Ethiopia Faces First Marburg Outbreak: Nine Infected in Health Crisis
Overview of the Outbreak Health authorities in Ethiopia and the World Health Organization (WHO) have confirmed nine infections linked to Marburg virus disease in the southern region of the country. Marburg is a highly contagious and often deadly disease that shares similarities with Ebola, including severe bleeding and multi-organ failure. This development marks the first…
-
WHO Approves First Child-Friendly Primaquine to Treat Malaria Relapse
Overview: A historic step in pediatric malaria care The World Health Organization has approved the first-ever child-friendly primaquine tablets for treating malaria relapse in children, marking a significant milestone in the global fight against malaria. This development, backed by collaboration between Medicines for Malaria Venture (MMV) and Fosun Pharma with funding and strategic support from…
-
WHO Approves First Child-Friendly Primaquine Tablets to Fight Malaria Relapses
Groundbreaking approval for pediatric malaria treatment The World Health Organization (WHO) has approved the first-ever child-friendly primaquine tablets designed to treat relapse-causing malaria in children. This milestone, made possible through collaboration between Medicines for Malaria Venture (MMV), Fosun Pharma, and support from Unitaid, marks a significant step toward safer, more effective malaria elimination strategies for…